The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co ... Sally Seymour of the FDA's Center for Drug Evaluation and Research.

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023.Although the new FDA green light doesn't expand the ...